52 results on '"Kajaste-Rudnitski A"'
Search Results
2. Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells
3. In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases
4. Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors
5. Constitutive IL-1RA production by modified immune cells protects against IL-1–mediated inflammatory disorders
6. Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
7. Interferon‐inducible phospholipids govern IFITM3‐dependent endosomal antiviral immunity
8. Towards improved yet regulated gene therapy for X-CGD
9. Protocol to differentiate monolayer human induced pluripotent stem cells into inflammatory responsive astrocytes
10. Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
11. Abstract 3297: IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy
12. DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes
13. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease
14. The lysine-rich intracellular loop and cell type-specific co-factors are required for IFITM3 antiviral immunity in hematopoietic stem cells
15. Corrigendum: Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
16. Lipid-Based Nanoparticles as Nonviral Gene Delivery Vectors
17. D-mannose suppresses macrophage IL-1β production
18. Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced Ex Vivo and In Vivo Genetic Engineering
19. Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering
20. Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer
21. Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
22. Some finite element estimates of ship collision event
23. Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically RelevantEx VivoGene Therapy Settings
24. Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells
25. Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells
26. Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy
27. Incremental Innovation of Ex Vivo Hematopoietic Stem Cell Engineering to Expand Clinical Gene Therapy Applications
28. HIV-1 silencing mediated by TRIM22 inhibition of Sp1 binding to the promoter
29. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter
30. 36. Genome-Wide Insight Into the Transcriptional Modulations Triggered By Lentiviral Transduction in Human Hematopoietic Stem Cells
31. 288. Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatous Disease
32. Cellular Innate Immunity and Restriction of Viral Infection: Implications for Lentiviral Gene Therapy in Human Hematopoietic Cells
33. Cyclosporin A and Rapamycin Relieve Distinct Lentiviral Restriction Blocks in Hematopoietic Stem and Progenitor Cells
34. Inhibition of influenza H5N1 invasion by modified heparin derivatives
35. Dual-regulated Lentiviral Vector for Gene Therapy of X-linked Chronic Granulomatosis
36. Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression
37. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease
38. M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication
39. TRIM22 Inhibits Influenza A Virus Infection by Targeting the Viral Nucleoprotein for Degradation
40. HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines
41. TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-κB-Responsive Long Terminal Repeat Elements
42. 224 The MHC-II Transactivator, CIITA, Inhibits Tat-Mediated HIV-1 LTR Transactivation and Virus Replication in Human U937 Monocytic Cells
43. 127 Characterization of Tripartite-Motif (TRIM) 22-Mediated Inhibition of HIV-1 Transcription
44. 112 Multifaceted Infection and Replication of HIV-1 in Human Macrophages
45. Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals
46. Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b
47. Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5α and 22
48. Pandemic Vaccine Preparedness—Have We Left Something Behind?
49. Inhibition of Herpes Simplex Virus Types 1 and 2 In Vitro Infection by Sulfated Derivatives of Escherichia coli K5 Polysaccharide
50. A dimerizable cationic lipid with potential for gene delivery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.